Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.28
+1.11 (4.09%)
Jun 9, 2026, 2:19 PM EDT - Market open
Hims & Hers Health Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -13.24 | 128.37 | 126.04 | -23.55 | -65.68 | -107.66 |
Depreciation & Amortization | 68.18 | 54.5 | 17.09 | 9.52 | 7.47 | 4.08 |
Stock-Based Compensation | 147.25 | 135.24 | 92.32 | 66.08 | 42.82 | 67.21 |
Other Adjustments | 60.89 | 11.06 | -62.99 | 0.61 | 3.05 | -1.49 |
Change in Receivables | -116.25 | - | - | - | - | - |
Changes in Inventories | -22.36 | -13.72 | -41.61 | -0.9 | -8 | -9.63 |
Changes in Accounts Payable | 183.47 | 30.3 | 43.71 | 7.32 | 12.72 | 9.85 |
Changes in Accrued Expenses | -37.39 | -43.05 | 23.79 | 16.52 | 0.91 | 0.2 |
Changes in Unearned Revenue | 54.1 | 51.6 | 67.55 | 6.26 | -1.72 | 1.41 |
Changes in Other Operating Activities | -48.44 | -54.29 | -14.82 | -8.39 | -18.11 | 1.62 |
Operating Cash Flow | 280.27 | 300.01 | 251.08 | 73.48 | -26.53 | -34.41 |
Operating Cash Flow Growth | -16.17% | 19.48% | 241.69% | - | - | - |
Capital Expenditures | -200.56 | -226.05 | -41.66 | -17.22 | -2.71 | -0.83 |
Purchases of Intangible Assets | -19.32 | -16.55 | -11.1 | -9.27 | -4.53 | -4.18 |
Purchases of Investments | -737.06 | -745.84 | -160.56 | -157.24 | -187.7 | -266.63 |
Proceeds from Sale of Investments | 247.32 | 108.7 | 209.67 | 171.63 | 230.11 | 161.84 |
Payments for Business Acquisitions | -277.99 | -145.23 | -15.4 | - | -0.46 | -46.47 |
Investing Cash Flow | -1,013 | -1,025 | -19.05 | -12.11 | 34.7 | -156.27 |
Long-Term Debt Issued | 485 | 970 | - | - | - | - |
Net Long-Term Debt Issued (Repaid) | 485 | 970 | - | - | - | - |
Issuance of Common Stock | 17.07 | 17.47 | 30.89 | 4.62 | 3.42 | 274.73 |
Repurchase of Common Stock | -89.96 | -89.96 | -83.04 | -2 | - | -22.03 |
Net Common Stock Issued (Repurchased) | -72.89 | -72.49 | -52.15 | 2.62 | 3.42 | 252.7 |
Other Financing Activities | -199.94 | -167.89 | -55.69 | -14.1 | -36.55 | -17.65 |
Financing Cash Flow | 218.67 | 729.62 | -107.85 | -11.48 | -33.13 | 235.04 |
Effect of Exchange Rate Changes on Cash and Cash Equivalents | -2.38 | - | - | - | - | - |
Net Cash Flow | -6.35 | 4.67 | 124.19 | 49.9 | -24.96 | 44.36 |
Free Cash Flow | 79.71 | 73.96 | 209.43 | 56.26 | -29.25 | -35.24 |
Free Cash Flow Growth | 7.77% | -64.68% | 272.23% | - | - | - |
FCF Margin | 3.36% | 3.15% | 14.18% | 6.45% | -5.55% | -12.96% |
Free Cash Flow Per Share | 0.32 | 0.29 | 0.88 | 0.27 | -0.14 | -0.19 |
Levered Free Cash Flow | 468.77 | 897.66 | 180.09 | -10.43 | -75.11 | -100.96 |
Unlevered Free Cash Flow | -13.62 | -91.31 | 162.86 | -19.03 | -78.1 | -105.09 |